For generations, cancer researchers have studied life by ending it — fixing cells in place, breaking them apart, capturing only a final moment rather than the living story. A new platform developed by Precigenetics now allows scientists to observe cells continuously, as they live and respond, filling the silence between the beginning and the end of an experiment. In a field where most drug candidates fail before reaching patients, this shift from biological autopsy to living observation may quietly reorder the possibilities of medicine.